Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Downgrades Surrozen to Underweight

JP Morgan Downgrades Surrozen to Underweight

JP Morgan analyst Eric Joseph downgrades Surrozen (NASDAQ:SRZN) from Neutral to Underweight.

byBenzinga Newsdesk

November 29, 2022

1 minute read

JP Morgan analyst Eric Joseph downgrades Surrozen (NASDAQ:SRZN) from Neutral to Underweight.

These Analysts Boost Their Forecasts On GoodRx Holdings After Q2 Results

By Lisa Levin

August 10, 11:34 AM

GoodRx Holdings Inc (NASDAQ: GDRX) reported better-than-expected second-quarter financial results.

GDRX

Analyst Ratings

What 4 Analyst Ratings Have To Say About Zimmer Biomet Holdings

By Benzinga Insights

July 15, 2:05 PM

Analysts have provided the following ratings for Zimmer Biomet Holdings (NYSE:ZBH) within the last quarter:

ZBH

Jim Cramer Says This Company Is ‘Second-Rate’ Logitech, Recommends Buying AMD

By Avi Kapoor

May 10, 8:41 AM

AMD chair and CEO Lisa Su is "doing a terrific job," Cramer said. The company's first-quarter results came in ahead of expectations.

AMD

CME Group Q3 Adj. EPS $1.98 Beats $1.91 Estimate, Sales $1.23B Beat $1.21B Estimate

By Benzinga Newsdesk

October 26, 7:03 AM

CME Group (NASDAQ:CME) reported quarterly earnings of $1.98 per share which beat the analyst consensus estimate of $1.91 by 3.66 percent. This is a 23.75 percent increase over earnings of $1.60 per share from the same

CME

JP Morgan Downgrades Surrozen to Underweight

Related Posts

These Analysts Boost Their Forecasts On GoodRx Holdings After Q2 Results

What 4 Analyst Ratings Have To Say About Zimmer Biomet Holdings

Jim Cramer Says This Company Is ‘Second-Rate’ Logitech, Recommends Buying AMD

CME Group Q3 Adj. EPS $1.98 Beats $1.91 Estimate, Sales $1.23B Beat $1.21B Estimate